Apex Biotechnology Corp (1733) — Cash Flow Reinvestment Rate
Apex Biotechnology Corp (1733) has a Cash Flow Reinvestment Rate of 1.77x as of September 2025, reinvesting NT$9.17 Million (capex NT$2.97 Million plus investments NT$6.21 Million) from operating cash flow of NT$5.19 Million. See Apex Biotechnology Corp (1733) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Apex Biotechnology Corp Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for Apex Biotechnology Corp across 23 annual periods. For the full cash flow conversion analysis, see 1733 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Apex Biotechnology Corp (2002–2024)
Year-by-year capital reinvestment analysis for Apex Biotechnology Corp. See Apex Biotechnology Corp leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | NT$35.63 Million | NT$328.67 Million | NT$29.63 Million | ▼ -47.4% |
| 2023 | 0.21x | NT$47.48 Million | NT$230.39 Million | NT$24.98 Million | ▼ -86.6% |
| 2022 | 1.54x | NT$40.90 Million | NT$26.62 Million | NT$40.20 Million | ▲ +880.3% |
| 2021 | 0.16x | NT$28.20 Million | NT$179.87 Million | NT$26.20 Million | ▼ -74.4% |
| 2020 | 0.61x | NT$171.51 Million | NT$280.60 Million | NT$48.32 Million | ▲ +112.3% |
| 2019 | 0.29x | NT$133.19 Million | NT$462.52 Million | NT$56.58 Million | ▼ -81.6% |
| 2018 | 1.56x | NT$105.52 Million | NT$67.57 Million | NT$75.29 Million | ▲ +312.9% |
| 2017 | 0.38x | NT$26.79 Million | NT$70.83 Million | NT$26.76 Million | ▲ +101.2% |
| 2016 | 0.19x | NT$56.03 Million | NT$298.06 Million | NT$38.45 Million | ▼ -5.2% |
| 2015 | 0.20x | NT$93.63 Million | NT$472.15 Million | NT$26.66 Million | ▼ -44.4% |
| 2014 | 0.36x | NT$95.47 Million | NT$267.60 Million | NT$65.41 Million | ▼ -40.9% |
| 2013 | 0.60x | NT$292.47 Million | NT$484.77 Million | NT$247.69 Million | ▼ -25.9% |
| 2012 | 0.81x | NT$414.70 Million | NT$509.67 Million | NT$414.70 Million | ▲ +198.1% |
| 2011 | 0.27x | NT$74.63 Million | NT$273.45 Million | NT$74.63 Million | ▼ -21.1% |
| 2010 | 0.35x | NT$161.05 Million | NT$465.59 Million | NT$161.05 Million | ▲ +84.6% |
| 2009 | 0.19x | NT$73.34 Million | NT$391.29 Million | NT$73.34 Million | ▼ -56.7% |
| 2008 | 0.43x | NT$129.74 Million | NT$299.96 Million | NT$129.74 Million | ▲ +188.3% |
| 2007 | 0.15x | NT$54.71 Million | NT$364.62 Million | NT$54.71 Million | ▲ +30.0% |
| 2006 | 0.12x | NT$41.99 Million | NT$363.71 Million | NT$41.99 Million | ▼ -69.9% |
| 2005 | 0.38x | NT$81.30 Million | NT$212.14 Million | NT$81.30 Million | ▼ -66.7% |
| 2004 | 1.15x | NT$251.16 Million | NT$218.54 Million | NT$251.16 Million | ▲ +518.0% |
| 2003 | 0.19x | NT$56.21 Million | NT$302.25 Million | NT$56.21 Million | ▼ -75.8% |
| 2002 | 0.77x | NT$61.13 Million | NT$79.49 Million | NT$61.13 Million | — |